Month: January 2022

John Rogers, PhD, has been awarded the 2022 James Prize in Science and Technology Integration by the Council of the National Academy of Sciences.

A new study has identified naturally occurring nano-sized particles that can block infection from broad strains of SARS-CoV-2 virus in preclinical studies.

Michael Wang, a fourth-year medical student, is the lead author of a study recently selected by the American Heart Association as one of the top heart disease and stroke research advances of 2021.

Feinberg scientists including the lab of William Muller, MD, PhD, are investigating how regulating inflammation can be a pathway to treating a range of diseases.

A new Northwestern study has discovered a technique to help make immunomodulation more effective, potentially improving treatment for type 1 diabetes.

Among patients with no detectable coronary artery calcium, those who smoke, have diabetes or hypertension have the highest risk of cardiovascular disease events, according to a recent study.

The laboratory of YouYang Zhao, PhD, developed a unique nanoparticle to deliver genome editing technology, including CRISPR/Cas9, to vascular endothelial cells.

A Northwestern Medicine study has found that a new combination immune therapy treatment not only extended cancer patients’ lives better than other treatments, it also was less toxic to their overall health than other drugs on the market.

Jane Winter, MD, a highly regarded lymphoma expert, will serve as president of the American Society of Hematology for a year-long term through December 2022.

Using MRI, EEG and clinical characteristics, the pre-surgical workup can predict if patients with epilepsy will benefit from a more invasive examination.